Skip to main content

Breast Hypoplasia and Facial Ageing

1
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
1
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Hamlet Biopharma
Hamlet BiopharmaSweden - Lund
1 program
1
ASC enriched lipofillingPhase 31 trial
Active Trials
NCT03258164Completed32Est. Nov 2022

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Hamlet BiopharmaASC enriched lipofilling

Clinical Trials (1)

Total enrollment: 32 patients across 1 trials

NCT03258164Hamlet BiopharmaASC enriched lipofilling

Cosmetic Fat Transplantation Using Expanded ASC Enriched Fat Grafts

Start: Mar 2017Est. completion: Nov 202232 patients
Phase 3Completed

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 late-stage (Phase 3) programs, potential near-term approvals
1 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.